in a significant improvement in TTO with an average reduction of 37 minutes compared with levodopa treatment ( p<0.0001 ... and also reduced the number of dose failuresresultedin a significant improvement in TTO with an average reduction of 37 minutes compared with levodopa treatment ( p<0.0001 ... and also reduced the number of dose failures
mild - to - moderate pain at the site of injectionmay causemild - to - moderate pain at the site of injection
in severe tissue necrosiscan resultin severe tissue necrosis
in local tissue reaction which may result in trim loss at slaughtermay resultin local tissue reaction which may result in trim loss at slaughter
this productcausedthis product
in a more rapid time - action profile than subcutaneous injectionresultsin a more rapid time - action profile than subcutaneous injection
to necrosis of the skin , subcutaneous tissue , and muscle tissueleadingto necrosis of the skin , subcutaneous tissue , and muscle tissue
a transient local tissue reaction that may result in trim loss of edible tissue at slaughtercan causea transient local tissue reaction that may result in trim loss of edible tissue at slaughter
TriamcinoloneresultsTriamcinolone
mild - to - moderate pain at the site of injection.[22may causemild - to - moderate pain at the site of injection.[22
the siteinfluencesthe site
to local ischemic necrosis of the skin andleadsto local ischemic necrosis of the skin and
local paincan causelocal pain
local paincauseslocal pain
in local tissue reaction that persists beyond 28 daysmay resultin local tissue reaction that persists beyond 28 days
in local tissue reaction which persists beyond 28 daysmay resultin local tissue reaction which persists beyond 28 days
local intense irritation pain , and even local tissue necrosiscan causelocal intense irritation pain , and even local tissue necrosis
to worse long - term outcomesleadsto worse long - term outcomes